N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine

C109H93N25O5 — CID 159825763

IUPACN-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine
SMILESCc1cc(Nc2nc(Oc3ccc4ccccc4c3)nc3ccccc23)n[nH]1.Cc1cc(Nc2nc(Oc3ccccc3)nc3ccccc23)n[nH]1.Cc1cccc(Oc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)c1.c1ccc2c(Nc3cc(C4CC4)[nH]n3)nc(Oc3ccc4c(c3)CCCC4)nc2c1.c1ccc2cc(Oc3nc(Nc4cc(C5CC5)[nH]n4)c4ccccc4n3)ccc2c1
InChIInChI=1S/C24H23N5O.C24H19N5O.C22H17N5O.C21H19N5O.C18H15N5O/c2*1-2-6-17-13-18(12-11-15(17)5-1)30-24-25-20-8-4-3-7-19(20)23(27-24)26-22-14-21(28-29-22)16-9-10-16;1-14-12-20(27-26-14)24-21-18-8-4-5-9-19(18)23-22(25-21)28-17-11-10-15-6-2-3-7-16(15)13-17;1-13-5-4-6-15(11-13)27-21-22-17-8-3-2-7-16(17)20(24-21)23-19-12-18(25-26-19)14-9-10-14;1-12-11-16(23-22-12)20-17-14-9-5-6-10-15(14)19-18(21-17)24-13-7-3-2-4-8-13/h3-4,7-8,11-14,16H,1-2,5-6,9-10H2,(H2,25,26,27,28,29);1-8,11-14,16H,9-10H2,(H2,25,26,27,28,29);2-13H,1H3,(H2,23,24,25,26,27);2-8,11-12,14H,9-10H2,1H3,(H2,22,23,24,25,26);2-11H,1H3,(H2,19,20,21,22,23)
InChIKeyNMUSCDTYEKORLM-UHFFFAOYSA-N
MW1833.11 g/mol
LogP26.19
Rot. Bonds23

About N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine

N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine (PubChem CID 159825763) has the molecular formula C109H93N25O5 and a molecular weight of 1833.11 g/mol. Its IUPAC name is N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine.

Molecular Properties

Compound NameN-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine
PubChem CID159825763
Molecular FormulaC109H93N25O5
Molecular Weight1833.11 g/mol
Exact Mass1831.78
IUPAC NameN-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine
SMILESCc1cc(Nc2nc(Oc3ccc4ccccc4c3)nc3ccccc23)n[nH]1.Cc1cc(Nc2nc(Oc3ccccc3)nc3ccccc23)n[nH]1.Cc1cccc(Oc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)c1.c1ccc2c(Nc3cc(C4CC4)[nH]n3)nc(Oc3ccc4c(c3)CCCC4)nc2c1.c1ccc2cc(Oc3nc(Nc4cc(C5CC5)[nH]n4)c4ccccc4n3)ccc2c1
InChIInChI=1S/C24H23N5O.C24H19N5O.C22H17N5O.C21H19N5O.C18H15N5O/c2*1-2-6-17-13-18(12-11-15(17)5-1)30-24-25-20-8-4-3-7-19(20)23(27-24)26-22-14-21(28-29-22)16-9-10-16;1-14-12-20(27-26-14)24-21-18-8-4-5-9-19(18)23-22(25-21)28-17-11-10-15-6-2-3-7-16(15)13-17;1-13-5-4-6-15(11-13)27-21-22-17-8-3-2-7-16(17)20(24-21)23-19-12-18(25-26-19)14-9-10-14;1-12-11-16(23-22-12)20-17-14-9-5-6-10-15(14)19-18(21-17)24-13-7-3-2-4-8-13/h3-4,7-8,11-14,16H,1-2,5-6,9-10H2,(H2,25,26,27,28,29);1-8,11-14,16H,9-10H2,(H2,25,26,27,28,29);2-13H,1H3,(H2,23,24,25,26,27);2-8,11-12,14H,9-10H2,1H3,(H2,22,23,24,25,26);2-11H,1H3,(H2,19,20,21,22,23)
InChIKeyNMUSCDTYEKORLM-UHFFFAOYSA-N
XLogP26.19
TPSA378.60 Ų
H-Bond Donors10
H-Bond Acceptors25
Rotatable Bonds23
Heavy Atoms139
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001833.11
LogP ≤ 526.19
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1025

Analyze N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(2-ethoxyphenyl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)quinazolin-4-amine;2-(2-ethylphenyl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)quinazolin-4-amine;2-[4-[(5-methyl-1H-1,2,4-triazol-3-yl)amino]quinazolin-2-yl]phenol;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-(2-phenylphenyl)quinazolin-4-amine;N-(5-methyl-1H-1,2,4-triazol-3-yl)-2-[2-(trifluoromethyl)phenyl]quinazolin-4-amine
CID 159664462
11-(4-methoxyphenyl)-10-methyl-8-phenyl-6,8-dihydro-5H-benzo[f]pyrazolo[3,4-b]quinoline
CID 139063637
N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine
CID 10222446
N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine
CID 10270315
N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine
CID 22254397
1-(1H-indol-3-yl)-N-[(7-morpholin-4-yl-2-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]methanimine;1-(6-methoxynaphthalen-2-yl)-N-[(7-morpholin-4-yl-2-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]methanimine;1-(3-methylphenyl)-N-[(7-morpholin-4-yl-2-pyrimidin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]methanimine;1-(3-methylphenyl)-N-[(7-morpholin-4-yl-2-quinolin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]methanimine;N-[(7-morpholin-4-yl-2-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-1-(3-propan-2-ylphenyl)methanimine;N-[(7-morpholin-4-yl-2-pyridin-4-yl-[1,2,4]triazolo[1,5-a]pyrimidin-5-yl)methyl]-1-pyridin-3-ylmethanimine
CID 157683784
2-(2-cyclopropylphenyl)-N-(5,7-difluoro-1H-indazol-3-yl)quinazolin-4-amine;2-(2-cyclopropylphenyl)-N-(1H-indazol-3-yl)quinazolin-4-amine;N-(5,7-difluoro-1H-indazol-3-yl)-2-(2-methoxyphenyl)quinazolin-4-amine;N-(1H-indazol-3-yl)-2-(2-methoxyphenyl)quinazolin-4-amine
CID 158070158
2-(2-tert-butylphenyl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)quinazolin-4-amine;2-(2-cyclopropylphenyl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)quinazolin-4-amine;bis(2-(2-methoxyphenyl)-N-(5-methyl-1H-1,2,4-triazol-3-yl)quinazolin-4-amine);2-[4-[(5-methyl-1H-1,2,4-triazol-3-yl)amino]quinazolin-2-yl]phenol
CID 161196781

Frequently Asked Questions

What is the IUPAC name of N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine?
The IUPAC name of N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine (CID 159825763) is N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine.
What is the SMILES notation for N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine?
The canonical SMILES for N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine is Cc1cc(Nc2nc(Oc3ccc4ccccc4c3)nc3ccccc23)n[nH]1.Cc1cc(Nc2nc(Oc3ccccc3)nc3ccccc23)n[nH]1.Cc1cccc(Oc2nc(Nc3cc(C4CC4)[nH]n3)c3ccccc3n2)c1.c1ccc2c(Nc3cc(C4CC4)[nH]n3)nc(Oc3ccc4c(c3)CCCC4)nc2c1.c1ccc2cc(Oc3nc(Nc4cc(C5CC5)[nH]n4)c4ccccc4n3)ccc2c1.
What is the InChIKey of N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine?
The InChIKey is NMUSCDTYEKORLM-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H23N5O.C24H19N5O.C22H17N5O.C21H19N5O.C18H15N5O/c2*1-2-6-17-13-18(12-11-15(17)5-1)30-24-25-20-8-4-3-7-19(20)23(27-24)26-22-14-21(28-29-22)16-9-10-16;1-14-12-20(27-26-14)24-21-18-8-4-5-9-19(18)23-22(25-21)28-17-11-10-15-6-2-3-7-16(15)13-17;1-13-5-4-6-15(11-13)27-21-22-17-8-3-2-7-16(17)20(24-21)23-19-12-18(25-26-19)14-9-10-14;1-12-11-16(23-22-12)20-17-14-9-5-6-10-15(14)19-18(21-17)24-13-7-3-2-4-8-13/h3-4,7-8,11-14,16H,1-2,5-6,9-10H2,(H2,25,26,27,28,29);1-8,11-14,16H,9-10H2,(H2,25,26,27,28,29);2-13H,1H3,(H2,23,24,25,26,27);2-8,11-12,14H,9-10H2,1H3,(H2,22,23,24,25,26);2-11H,1H3,(H2,19,20,21,22,23).
What are the key properties of N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine?
N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine has a molecular weight of 1833.11 g/mol, XLogP of 26.19, 23 rotatable bonds, 10 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(3-methylphenoxy)quinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-(5,6,7,8-tetrahydronaphthalen-2-yloxy)quinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-naphthalen-2-yloxyquinazolin-4-amine;N-(5-methyl-1H-pyrazol-3-yl)-2-phenoxyquinazolin-4-amine is sourced from PubChem (CID 159825763), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).